Company Overview and News

 
Data-Driven Stock Picks: Growth Stocks

2018-04-17 seekingalpha
A current list of stock picks is presented which reflects the system output as of Monday, April 16.
Upvote Downvote

 
Gentex: Not Enough Upside Left

2018-04-17 seekingalpha
The tax tailwind, balance sheet strength, and niche moat make the company a relatively safe bet.
Upvote Downvote

 
Gentex Reports First Quarter 2018 Earnings Release Date and Conference Call

2018-04-04 globenewswire
ZEELAND, Mich., April 04, 2018 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ:GNTX), the Zeeland, Michigan-based manufacturer of automotive automatic-dimming rearview mirrors, automotive electronics, dimmable aircraft windows and fire protection products, is pleased to announce that it will release its 2018 first quarter financial results on Friday, April 20 before the market opens. The Company will host a conference call for the investment community at 9:30am ET to discuss the results.
Upvote Downvote

 
GNTX / Gentex Corp. DEF 14A

2018-04-03 sec.gov
Document
Upvote Downvote

 
GNTX / Gentex Corp. DEFA14A

2018-04-03 sec.gov
gentexcorporationnotice2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant
Upvote Downvote

 
Winnebago (WGO) Q2 Earnings Lag Estimates, Revenues Top

2018-03-22 zacks
Winnebago Industries Inc. (WGO - Free Report) registered adjusted earnings of 62 cents per share in the second quarter of fiscal 2018 (ended Feb 24, 2018), missing the Zacks Consensus Estimate of 65 cents. In the year-ago period, earnings were 48 cents per share. However, net income soared 44.6% to $22.1 million.
Upvote Downvote

 
Toyota (TM) to Gain From Cost-Cut Initiatives, Global Sales

2018-03-22 zacks
On Mar 21, we issued an updated research report on Toyota Motor Corporation (TM - Free Report) .
Upvote Downvote

 
BRIEF-Gentex Announces Capital Allocation Strategy

2018-03-09 reuters
* GENTEX ANNOUNCES CAPITAL ALLOCATION STRATEGY, ADDITIONAL SHARE REPURCHASE AUTHORIZATION AND 10% INCREASE IN QUARTERLY CASH DIVIDEND
Upvote Downvote

 
February Dividend Income Report

2018-03-09 seekingalpha
Back in September 2017, I received slightly over $100K as a result of the commuted value of my pension plan. I decided to invest 100% of this money into dividend growth stocks. Each month, I publish my results. I don’t do this to brag; I do this to show you it’s possible to build a portfolio during an all-time-high market. The market will crash… eventually. In the meantime, I’d rather cash some juicy dividends!
Upvote Downvote

 
Group 1 Automotive (GPI) Rides on Dealership Expansions

2018-03-06 zacks
On Mar 5, we issued an updated research report on Group 1 Automotive, Inc. (GPI - Free Report) . The company regularly engages in the acquisition and divestment of dealerships and franchises so as to expand its business. This is expected to increase its annualized revenues. In January 2018, Group 1 Automotive acquired two dealerships in Texas in order to strengthen its footprint in the rapidly growing El Paso market.
Upvote Downvote

 
Lithia (LAD) Acquires 6 Auto Stores, Adds $900M Revenue

2018-03-05 zacks
Lithia Motors, Inc. (LAD - Free Report) has made the announcement of acquiring six auto stores from Prestige Family of Fine Cars in Bergen County, NJ. The acquired stores include a BMW, Mini, Mercedes, Toyota and two Lexus stores and this acquisition is likely to generate steady state revenues of $900 million, annually. Located in Paramus and Ramsey, these stores will add to the diversification mix of Lithia Motors in the Northeast and will strengthen its offerings of luxury products.
Upvote Downvote

 
Gentex Corp. Is A Steal If It Can Capitalize On This Trend

2018-03-05 seekingalpha
The Pros include no long-term debt, value being returned to shareholders in 4 different ways, and the company being financially responsible.
Upvote Downvote

 
You Retire In 10+ Years? Here's My Top Picks For Your Portfolio

2018-02-27 seekingalpha
If you invest for the long haul, you don’t have to focus on the dividend yield.
Upvote Downvote

 
Magna (MGA) Q4 Earnings & Revenues Drive Past Estimates

2018-02-23 zacks
Magna International, Inc. ((MGA - Free Report) reported fourth-quarter 2017 adjusted earnings per share of $1.57, surpassing the Zacks Consensus Estimate by a cent. The bottom line also improved 20% from $1.31 recorded in the same period of 2016.
Upvote Downvote

1
GNTX / Gentex Corp. 10-K (Annual Report)

2018-02-21 sec.gov
Document UNITED STATES
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 371901109